Cargando…
Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
After more than a decade of preclinical and clinical development, therapeutic infusion of mesenchymal stromal cells is now a leading investigational strategy for the treatment of acute graft-versus-host disease (GVHD). While their clinical use continues to expand, it is still unknown which of their...
Autores principales: | Dunavin, Neil, Dias, Ajoy, Li, Meizhang, McGuirk, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618297/ https://www.ncbi.nlm.nih.gov/pubmed/28671556 http://dx.doi.org/10.3390/biomedicines5030039 |
Ejemplares similares
-
Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease
por: McGuirk, Joseph P., et al.
Publicado: (2015) -
Clinical characteristics and treatment outcome of patients with isochromosome 17q (i17q) abnormality and myeloid neoplasms: A single center experience
por: Ganguly, Siddhartha, et al.
Publicado: (2018) -
Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
por: Cheung, Tik Shing, et al.
Publicado: (2020) -
WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1
por: Li, Meizhang, et al.
Publicado: (2021) -
Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
por: Kelly, Kilian, et al.
Publicado: (2021)